Search Results

CytoTronics, Inc. revealed its new Pixel ™ system at the 2024 Society for Laboratory Automation and Screening ( SLAS ) international conference and exhibition in Boston, MA.

Harvard University spinout advances a unique complementary metal-oxide-semiconductor -powered drug discovery platform that opens a new dimension in cell-based screening

The Center for Devices and Radiological Health of the U.S. Food and Drug Administration granted Shreis Scalene Sciences, in Gaithersburg, MD, ‘Breakthrough Device Designation’ for the CYTOTRON® - a CE marked, whole-body therapeutic medical device.

Dianthus Therapeutics, Enavate Sciences and CytoTronics were all launched with this recent wave of investor funding. For that and more, continue reading.

Shreis Scalene Therapeutics LLC (SSTx), a MD-USA-based medical device company has fast-tracked the marketing and distribution of the CE-marked (EU-Class 1) Scalene Hypercharge Corona Canon (SHYCOCAN®), that is currently market-enabled under “US FDA’s ‘Enforcement Policy for Sterilizers, Disinfectant Devices, and Air Purifiers During the Coronavirus Disease 2019

Shreis Scalene Therapeutics LLC (SSTx), a MD-USA-based medical device company has fast-tracked the marketing and distribution of the CE-marked (EU-Class 1) Scalene Hypercharge Corona Canon (SHYCOCAN ® )